# Study of Intradermal Injections of RCS-01 in Male and Female Subjects

> **NCT02391935** · PHASE1 · COMPLETED · sponsor: **RepliCel Life Sciences, Inc.** · enrollment: 17 (actual)

## Conditions studied

- Intrinsic Aging of Skin
- Skin Wrinkling
- Solar Degeneration of Skin

## Interventions

- **DRUG:** RCS-01
- **DRUG:** Placebo
- **DEVICE:** Sham injection

## Key facts

- **NCT ID:** NCT02391935
- **Lead sponsor:** RepliCel Life Sciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-10
- **Primary completion:** 2017-07-12
- **Final completion:** 2017-07-12
- **Target enrollment:** 17 (ACTUAL)
- **Last updated:** 2017-10-11

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02391935

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02391935, "Study of Intradermal Injections of RCS-01 in Male and Female Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02391935. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*